McDonnell Michael R. — SEC Form 4 filings
SEC reporting owner CIK 1121897. 13 Form 4 filings on record with FilingPulse; latest filed 2026-07-10.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-01-31 to 2026-07-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 3,500 shares, $330,418 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 32.
- Largest priced transaction: sale of 1,750 shares @ $94.51 ($165,392) in MERIT MEDICAL SYSTEMS INC, filed 2025-06-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| MERIT MEDICAL SYSTEMS INC (MMSI) | Director | 4 | — | 2 legs · 3,500 sh · $330,418 | 3 |
| BIOGEN INC. (BIIB) | EVP, Chief Financial Officer | 6 | — | — | 24 |
| Moderna, Inc. (MRNA) | Director | 1 | — | — | 3 |
| BAXTER INTERNATIONAL INC (BAX) | Director | 2 | — | — | 2 |
Form 4 filings — McDonnell Michael R.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-10 | 4 | Moderna, Inc. (MRNA) | Grant/award (A): 7,415 (derivative) @ $0 · Grant/award (A): 1,618 (derivative) @ $0 · Grant/award (A): 5,733 (derivative) @ $0 | EDGAR |
| 2026-05-19 | 4 | MERIT MEDICAL SYSTEMS INC (MMSI) | Grant/award (A): 3,457 @ $0 | EDGAR |
| 2026-05-07 | 4 | BAXTER INTERNATIONAL INC (BAX) | Grant/award (A): 12,836 @ $0 | EDGAR |
| 2026-02-18 | 4 | BAXTER INTERNATIONAL INC (BAX) | Grant/award (A): 1,811 @ $0 | EDGAR |
| 2025-06-03 | 4 | MERIT MEDICAL SYSTEMS INC (MMSI) | Sale (S): 1,750 @ $94.30 · Sale (S): 1,750 @ $94.51 | EDGAR |
| 2025-05-19 | 4 | MERIT MEDICAL SYSTEMS INC (MMSI) | Grant/award (A): 2,152 @ $0 | EDGAR |
| 2025-02-12 | 4 | BIOGEN INC. (BIIB) | Option exercise (M): 3,257 @ $0 · Tax withholding (F): 1,371 @ $142.54 · Option exercise (M): 3,257 (derivative) @ $0 | EDGAR |
| 2025-02-10 | 4 | BIOGEN INC. (BIIB) | Option exercise (M): 2,335 @ $0 · Tax withholding (F): 786 @ $141.35 · Option exercise (M): 2,216 @ $0 · Tax withholding (F): 716 @ $141.35 · Option exercise (M): 2,335 (derivative) @ $0 · Option exercise (M): 2,216 (derivative) @ $0 | EDGAR |
| 2024-05-20 | 4 | MERIT MEDICAL SYSTEMS INC (MMSI) | Grant/award (A): 2,431 @ $0 | EDGAR |
| 2024-02-21 | 4 | BIOGEN INC. (BIIB) | Option exercise (M): 4,568 @ $0 · Tax withholding (F): 2,337 @ $219.08 · Option exercise (M): 2,152 @ $0 · Tax withholding (F): 1,101 @ $219.08 · Option exercise (M): 4,568 (derivative) @ $0 · Option exercise (M): 2,152 (derivative) @ $0 · +1 more | EDGAR |
| 2024-02-13 | 4 | BIOGEN INC. (BIIB) | Option exercise (M): 3,257 @ $0 · Tax withholding (F): 1,431 @ $240.98 · Option exercise (M): 3,257 (derivative) @ $0 | EDGAR |
| 2024-02-09 | 4 | BIOGEN INC. (BIIB) | Option exercise (M): 2,335 @ $0 · Tax withholding (F): 765 @ $240.30 · Grant/award (A): 6,650 (derivative) @ $0 · Option exercise (M): 2,335 (derivative) @ $0 | EDGAR |
| 2024-01-31 | 4 | BIOGEN INC. (BIIB) | Grant/award (A): 4,568 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1121897 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →